Business
Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities for Sotrovimab (Xevudy) include increased prevalence of COVID-19, necessitating early-stage treatment and high-risk patient protection; rising healthcare investments supporting R&D and expanded access; strategic collaborations enhancing development; and expanding regional biologics manufacturing in response to tariffs.Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Sotrovimab or Xevudy Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has be
About this update from Vir Biotechnology, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Key market opportunities for Sotrovimab (Xevudy) include increased prevalence of COVID-19, necessitating early-stage treatment and high-risk patient protection; rising healthcare investments supporting R&D and expanded access; strategic collaborations enhancing development; and expanding regional biologics manufacturing in response to tariffs.","length":349,"tagName":"p"},{"type":"text","content":"Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Sotrovimab or Xevudy Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":220,"tagName":"p"},{"type":"text","content":"The report offers invaluable insights for strategists, marketers, and senior management seeking to navigate this rapidly expanding market. A focal point of growth, the sotrovimab or xevudy market is set to shape health and pharmaceutical trends over the next decade.","length":266,"tagName":"p"},{"type":"text","content":"The historic growth of the Sotrovimab (Xevudy) market was driven by the emergency authorization of COVID-19 monoclonal antibodies, a high hospitalization risk during the early pandemic phases, rapid deployment of antibody therapies, and government procurement of antiviral treatments. The expansion of infusion-based treatment infrastructure further supported this growth.","length":372,"tagName":"p"},{"type":"text","content":"Looking ahead, the market is expected to expand due to the evolution of variant-resistant antibody therapies and a growing focus on preparedness for future pandemics. Increased investment in antiviral biologics, the ex...